<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical evidence. In a review on the effects of non-steroidal anti-inflammatory drugs (NSAIDs) for treating pain or respiratory symptoms (e.g., cough associated with the common cold), the conclusion was NSAIDs are somewhat effective in relieving the discomfort caused by cold. However, there is no clear evidence of their effect in easing respiratory symptoms. Therefore, the balance of benefits and risks needs to be considered when using NSAIDs for colds (
 <xref rid="B270" ref-type="bibr">Kim et al., 2013</xref>). There is an ongoing clinical trial in the UK with COVID-19 patients receiving a liquid ibuprofen formulation on top of standard care (
 <xref rid="B93" ref-type="bibr">ClinicalTrials.gov, 2020</xref>). Overall, the clinical evidence is High.
</p>
